Is Twist Bioscience Corp well-positioned for December economic uncertainties?

The big decline in price over the last few months for Twist Bioscience created some momentum for private investors as it was traded today as low as 25.62 and as high as 29.5 per share. The company executives failed to add value to investors and position the company supply of money to exploit market volatility in October. However, diversifying your holdings with Twist Bioscience Corp or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.54. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Twist Bioscience Corp partners.

As of the 18th of November 2022, Twist Bioscience has the coefficient of variation of (864.13), and Risk Adjusted Performance of (0.16). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Twist Bioscience Corp, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for Twist Bioscience Corp, which can be compared to its competition. Please validate Twist Bioscience Corp coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Twist Bioscience is priced more or less accurately, providing market reflects its prevalent price of 25.76 per share. Given that Twist Bioscience Corp has jensen alpha of (0.72), we advise you to double-check Twist Bioscience Corp's current market performance to make sure the company can sustain itself at a future point.